Cumberland Pharmaceuticals
CPIX
26 hedge funds and large institutions have $8.17M invested in Cumberland Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
0.32% more ownership
Funds ownership: 19.21% → 19.53% (+0.32%)
0% more funds holding
Funds holding: 26 → 26 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
38% less capital invested
Capital invested by funds: $13.2M → $8.17M (-$5.06M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$224K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$168K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$136K |
| 4 |
Renaissance Technologies
New York
|
+$127K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$373K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$104K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$94K |
| 4 |
State Street
Boston,
Massachusetts
|
-$79K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$62K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
26
Two Sigma Securities
New York
| – | -$104K | -22,354 | Closed |
|
|
SSA
27
Schonfeld Strategic Advisors
New York
| – | -$94K | -20,200 | Closed |
|
|
PPA
28
Parametric Portfolio Associates
Seattle,
Washington
| – | -$49K | -10,466 | Closed |
|
29
Bank of America
Charlotte,
North Carolina
| – | -$67 | -20 | -16% |
|
CPIX Hedge Fund Activity: Q1 2022 in Review
26 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2022, worth a combined $8.17M — down 38% from $13.2M a quarter earlier.
Fund positioning in CPIX was balanced in Q1 2022: 4 funds opened new positions, 4 closed out, 9 added to existing stakes and 6 trimmed.
The largest buyer was Two Sigma Advisers, adding an estimated $224K. The largest seller was Marshall Wace, exiting entirely with an estimated $373K sold.
- 26 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $8.17M of Cumberland Pharmaceuticals stock for Q1 2022, down 38% quarter-over-quarter.
- 4 funds opened new Cumberland Pharmaceuticals positions in Q1 2022 and 4 closed out, a net change of 0 holders.
- The largest Cumberland Pharmaceuticals buyer in Q1 2022 was Two Sigma Advisers, an estimated $224K added.
- The largest Cumberland Pharmaceuticals seller in Q1 2022 was Marshall Wace, an estimated $373K sold.
Based on aggregated 13F filings for Q1 2022.